Cargando…
(99m)Tc-Labeled Iron Oxide Nanoparticles as Dual-Modality Contrast Agent: A Preliminary Study from Synthesis to Magnetic Resonance and Gamma-Camera Imaging in Mice Models
The combination of two imaging modalities in a single agent has received increasing attention during the last few years, since its synergistic action guarantees both accurate and timely diagnosis. For this reason, dual-modality contrast agents (DMCAs), such as radiolabeled iron oxide (namely Fe(3)O(...
Autores principales: | Karageorgou, Maria-Argyro, Rapsomanikis, Aristotelis-Nikolaos, Mirković, Marija, Vranješ-Ðurić, Sanja, Stiliaris, Efstathios, Bouziotis, Penelope, Stamopoulos, Dimosthenis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370270/ https://www.ncbi.nlm.nih.gov/pubmed/35957159 http://dx.doi.org/10.3390/nano12152728 |
Ejemplares similares
-
Radiolabeled Iron Oxide Nanoparticles as Dual Modality Contrast Agents in SPECT/MRI and PET/MRI
por: Karageorgou, Maria-Argyro, et al.
Publicado: (2023) -
Immunocompatibility of a new dual modality contrast agent based on radiolabeled iron-oxide nanoparticles
por: Karageorgou, Maria-Argyro, et al.
Publicado: (2021) -
Gallium-68 Labeled Iron Oxide Nanoparticles Coated with 2,3-Dicarboxypropane-1,1-diphosphonic Acid as a Potential PET/MR Imaging Agent: A Proof-of-Concept Study
por: Karageorgou, Maria-Argyro, et al.
Publicado: (2017) -
A Novel Metal-Based Imaging Probe for Targeted Dual-Modality SPECT/MR Imaging of Angiogenesis
por: Tsoukalas, Charalampos, et al.
Publicado: (2018) -
Gamma grama tiroideo con Tc99m
por: Zepeda Alfonso, Alfredo de Jesús
Publicado: (2016)